Intelligence coverage: 65%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

ACOG

Alpha Cognition Inc.

Healthcare · Biotech

$8.47Sep 25, 2026

AI confidence 71% · refreshes every 15s during session

Investment Snapshot

Weak evidence · 1 source

Why it matters

Alpha Cognition Inc. shows accelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +267% YoY in Q2 FY2026.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue +267% YoY in Q2 FY2026

Pipeline evidence · 22d ago

ACOG's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on ACOG.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full ACOG earnings analysis

Reported figures for Alpha Cognition Inc. — research only, not investment advice.

Revenue YoY
+266.9%

Latest Intelligence

Updated

What happened recently for Alpha Cognition Inc. (ACOG) — events, not interpretation.

Event
Reported Q2 2026 revenue +267% YoY.
Also
Last session September 25, 2026 at $8.47.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Loading earnings intelligence…

Alpha Cognition Inc. (ACOG)

Healthcare · Biotech

Investment Snapshot above is the primary AlphaOS analysis for Alpha Cognition Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Industry:
Biotech
Market cap:
$184.46M
Revenue:
$6.09M

ACOG earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Alpha Cognition Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.